Welcome to the international HTA database

Showing [23537 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2020	Health Information and Quality Authority (HIQA)	Budget Impact Analysis – The Irish National Early Warning System (INEWS)
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Naldemedine (opioid-induced constipation) - Addendum to Commission A20-45]
2020	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Efficiency of 3D reconstruction in maxillofacial surgery]
2020	Health Information and Quality Authority (HIQA)	Evidence summary for the duration of infectiousness in those that test positive for SARS-CoV-2 RNA
2020	NIHR Health Technology Assessment programme	Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Lung cancer screening using low-dose computed tomography]
2020	Agency for Healthcare Research and Quality (AHRQ)	Interventions for breathlessness in patients with advanced cancer
2020	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Evaluation of the clinical effectiveness and safety of primary shoulder arthroplasty]
2020	Health Information and Quality Authority (HIQA)	Identification of guidance for pre-hospital emergency services and patient transport services in the context of COVID-19 and beyond
2020	NIHR Health Technology Assessment programme	The Namaste Care intervention to improve the quality of dying for people with advanced dementia living in care homes: a realist review and feasibility study for a cluster randomised controlled trial
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Collagen-covered and periosteum-covered autologous chondrocyte implantation in the knee joint as well as matrix-associated autologous chondrocyte implantation in the knee joint]
2020	Agency for Healthcare Research and Quality (AHRQ)	Interventions for substance use disorders in adolescents: a systematic review
2020	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Halcyon intensity-modulated beam conformal image-guided volumetric radiotherapy system for oncology treatment]
2020	Health Information and Quality Authority (HIQA)	Review of guidance for the operation of emergency medical dispatch centres in the context of COVID-19 and beyond
2020	NIHR Health Technology Assessment programme	Non-contact infrared thermometers for measuring body temperature in acutely ill children: a method comparison study
2020	NIHR Health Services and Delivery Research programme	Effects of increased distance to urgent and emergency care facilities resulting from health services reconfiguration: a systematic review
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Decision aid for amputations in diabetic foot syndrome - Rapid Report]
2020	Health Information and Quality Authority (HIQA)	Rapid review of public health guidance on identification and management of symptoms in children and young people attending school in the context of COVID-19
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Luspatercept (beta-thalassaemia) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020	Agency for Healthcare Research and Quality (AHRQ)	Labor dystocia
2020	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical Practice Guidelines on the diagnosis and treatment of non-serious blunt chest trauma]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Luspatercept (myelodysplastic syndromes) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020	NIHR Health Technology Assessment programme	CARer-ADministration of as-needed sub-cutaneous medication for breakthrough symptoms in home-based dying patients: a UK study (CARiAD)
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Rapid review: alternatives to timolol for the treatment of glaucoma]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ledipasvir/sofosbuvir (chronic hepatitis C in children) - Benefit assessment according to §35a Social Code Book V]
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Comparative results of the different screening strategies used for T21, T18 and T13: adaptation of the EUnetHTA assessment]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Sofosbuvir (chronic hepatitis C in children) - Benefit assessment according to §35a Social Code Book V]
2020	Agency for Care Effectiveness (ACE)	Sodium-glucose co-transporter 2 (SGLT2) inhibitors for type 2 diabetes mellitus
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ixekizumab (spondylitis and spondyloarthritis) - Benefit assessment according to §35a Social Code Book V]
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Spyglass® cholangiopancreatoscopy for biliary and pancreatic diseases]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ravulizumab (atypical haemolytic uraemic syndrome) - Benefit assessment according to §35a Social Code Book V]
2020	Agency for Healthcare Research and Quality (AHRQ)	Management of colonic diverticulitis
2020	NIHR Health Services and Delivery Research programme	Factors influencing the utilisation of free-standing and alongside midwifery units in England: a mixed methods research study
2020	Austrian Institute for Health Technology Assessment (AIHTA)	Update 12 months follow-up: Nusinersen in spinal muscular atrophy ("late onset") in children and adolescents ≥ 6 years
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ixekizumab (plaque psoriasis in children and adolescents) - Benefit assessment according to §35a Social Code Book V]
2020	NIHR Health Technology Assessment programme	Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT
2020	Ontario Health	Implantable devices for single-sided deafness and conductive or mixed hearing loss: a health technology assessment
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Angioplasty with stent placement in patients with carotid artery disease]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Talazoparib (breast cancer) - Addendum to Commission A20-48]
2020	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Leadless pacemaker for right ventricle pacing (Update 2020)
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Precice® intramedullary nail system, with external remote controller, for limb length discrepancy]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Nintedanib (systemic sclerosis associated interstitial lung disease in adults) - Benefit assessment according to §35a Social Code Book V]
2020	Haute Autorite de sante (HAS)	[New bariatric surgery techniques: identification, progress report and assessment opportunities]
2020	NIHR Health Technology Assessment programme	Adding web-based behavioural support to exercise referral schemes for inactive adults with chronic health conditions: the e-coachER RCT
2020	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Extracorporeal cytokine haemadsorption therapy in patients with sepsis or SIRS. Update 2020
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Fetal neurosonography in suspected central nervous system abnormalities]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Nintedanib (interstitial lung disease) - Benefit assessment according to §35a Social Code Book V]
2020	Ontario Health	Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment
2020	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure
2020	The National Health Care Institute (ZIN, Zorginstituut Nederland)	Emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in patients with severe haemophilia A without inhibitors
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Renal replacement therapies in acute kidney failure]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Trifarotene (acne vulgaris) - Benefit assessment according to §35a Social Code Book V]
2020	Agency for Healthcare Research and Quality (AHRQ)	Management of primary headaches in pregnancy
2020	Ontario Health	Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment
2020	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Intrauterine ultrasound-guided transcervical radiofrequency ablation
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Intravascular ultrasound in coronary artery disease]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Indacaterol acetate/glycopyrronium bromide/mometasone furoate (asthma) - Benefit assessment according to §35a Social Code Book V]
2020	Center for Drug Evaluation (CDE)	The health technology assessment of bipolar TURP, bipolar TUVP (vaporization of the prostate), Green Light TM, thulium, holmium, and diode laser prostatectomy in Taiwan
2020	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Percutaneous Transvascular Implantation of a Coronary Sinus Reducing Stent
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Human papilloma virus (HPV) vaccine in patients with HPV lesions or infection]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Relationship between volume of services and quality of treatment outcome for heart transplantations in adults - Rapid Report]
2020	National Institute for Health and Care Excellence (NICE)	Zio XT for detecting cardiac arrhythmias. NICE medical technologies guidance 52
2020	NIHR Health Technology Assessment programme	Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT
2020	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Radiofrequency-Induced Intravesical Chemohyperthermia for Non-Muscle-Invasive Bladder Cancer
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Summary: investigation, treatment and follow-up algorithm - lung cancer]
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Parenteral infusion pump during general hospital ward]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Glasdegib (acute myeloid leukaemia) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020	National Institute for Health and Care Excellence (NICE)	SEM Scanner 200 for preventing pressure ulcers. NICE medical technologies guidance 51
2020	Ontario Health	Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment
2020	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Vascular-targeted photodynamic therapy with padeliporfin (Tookad® Soluble)
2020	Scottish Health Technologies Group (SHTG)	Second-generation colon capsule endoscopy (CCE-2) for the detection of colorectal polyps – SHTG Recommendation
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Angioplasty with stent placement in patients with deep vein thrombosis]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ivacaftor/tezacaftor/elexacaftor (cystic fibrosis, combination regimen with ivacaftor in patients aged 12 years and older [homozygous for the F508del mutation]) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020	National Institute for Health and Care Excellence (NICE)	Axonics sacral neuromodulation system for treating refractory overactive bladder. NICE medical technologies guidance 50
2020	NIHR Health Technology Assessment programme	The association between primary care quality and health-care use, costs and outcomes for people with serious mental illness: a retrospective observational study
2020	Ontario Health	Cell-Free Circulating Tumour DNA Blood Testing to Detect EGFR T790M Mutation in People With Advanced Non–Small Cell Lung Cancer: A Health Technology Assessment
2020	National Authority for Assessment and Accreditation in Healthcare (INEAS)	[Statins, lifestyle and dietary interventions to prevent cardiovascular disease]
2020	Scottish Health Technologies Group (SHTG)	Pre-treatment DPYD genetic testing for patients who are prescribed chemotherapy involving fluoropyrimidines – SHTG Assessment
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Bulevirtide (chronic hepatitis delta virus infection) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020	National Institute for Health and Care Excellence (NICE)	Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia. NICE medical technologies guidance 49
2020	Health Information and Quality Authority (HIQA)	Evidence summary for accuracy of molecular and antigen detection tests for the diagnosis of COVID-19 using alternative clinical specimens or sites
2020	Scottish Health Technologies Group (SHTG)	Continuous glucose monitoring in pregnant women with type 1 diabetes – SHTG Adaptation
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Digital tomosynthesis for breast cancer]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ivacaftor/tezacaftor/elexacaftor (cystic fibrosis, combination regimen with ivacaftor in patients aged 12 years and older [heterozygous for F508del and MF mutation]) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020	National Institute for Health and Care Excellence (NICE)	PneuX to prevent ventilator-associated pneumonia. NICE medical technologies guidance 48
2020	Health Information and Quality Authority (HIQA)	Evidence summary for the relative importance of droplet versus contact transmission to the spread of SARS-CoV-2
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Target next generation sequencing-based gene panels in tumors of unknown origin]
2020	Agency for Care Effectiveness (ACE)	Dutasteride, tamsulosin, alfuzosin and dutasteride/tamsulosin combination for treating benign prostatic hyperplasia
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Alpelisib (breast cancer) - Benefit assessment according to §35a Social Code Book V]
2020	National Institute for Health and Care Excellence (NICE)	Episcissors-60 for mediolateral episiotomy. NICE medical technologies guidance 47
2020	Health Information and Quality Authority (HIQA)	Evidence summary for airborne transmission of SARS-CoV-2 via aerosols
2020	Scottish Health Technologies Group (SHTG)	Endobronchial valves for lung volume reduction in patients with severe or very severe emphysema - SHTG Recommendation
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Platelet rich plasma in musculoskeletal conditions]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Entrectinib (NSCLC) - Benefit assessment according to §35a Social Code Book V]
2020	Health Information and Quality Authority (HIQA)	Rapid review of public health guidance on universal face mask use by healthcare workers in the context of COVID-19
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Image-guided radiation therapy in liver and lung tumors]
2020	Agency for Care Effectiveness (ACE)	Direct-acting antiviral agents for treating genotype 1 chronic hepatitis C
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Secukinumab (plaque psoriasis in children and adolescents) - Benefit assessment according to §35a Social Code Book V]
2020	Agency for Healthcare Research and Quality (AHRQ)	No-touch modalities for disinfecting patient rooms in acute care settings: a rapid review
2020	Health Information and Quality Authority (HIQA)	Evidence summary for universal face mask use by healthcare workers in the context of COVID-19